Landos (LABP) Secures AbbVie Deal: Propelling Novel Oral Therapy Development
Fahim Awan
March 25, 2024
The current surge of Landos Biopharma, Inc. (NASDAQ: LABP) shares on the US charts, marking a notable surge of 168.27% to $21.46 per share as